Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-12
2006-09-12
Coleman, Brenda (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07105679
ABSTRACT:
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and processes for their preparation. The compounds of the invention are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosis; hormone sensitive cancers and hyperplasia of the breast, endometrium, cervix and prostate; endometriosis, uterine fibroids, osteoarthritis and as contraceptive agents, alone or in combination with a progestogen or progestogen antagonist.
REFERENCES:
patent: 5395842 (1995-03-01), Labrie et al.
patent: 5686465 (1997-11-01), Labrie et al.
patent: 5840735 (1998-11-01), Labrie et al.
patent: 6060503 (2000-05-01), Labrie et al.
patent: 6133458 (2000-10-01), Bell et al.
patent: 6153768 (2000-11-01), Jo et al.
patent: 0470310 (1992-02-01), None
patent: 1094806 (1967-12-01), None
patent: 173337 (1994-04-01), None
patent: WO 93/10741 (1993-06-01), None
patent: WO 96/26201 (1996-08-01), None
patent: WO 9709044 (1997-03-01), None
patent: WO 03053977 (2003-07-01), None
PCT International Search Report for International Application PCT/US03/37419, dated Mar. 16, 2004.
Albert, J.L. et al.: “Estrogen Regulation of Placental Alkaline Phosphatase Gene Expression in a Human Endometrial Adenocarcinoma Cell Line1”; Cancer Research 50, 1990, pp. 3306-3310.
Allan, G.F. et al.: “An Ultrahigh-Throughput Screening Assay for Estrogen Receptor Ligands”; Analytical Biochem. 275, 1999, pp. 243-247.
Baran-Marszak, M. et al.: “Nouvelle synthese de lla dehydrorotenone et d'autres rotenoides (*)”; No. 34., Manuscript date Jul. 21, 1970; pp. 191-198, 1970.
Cornia, M. et al.: “Oxygen Heterocycles By Oxidation ofortho-Alkylphenols. Oxidation ofortho-Propenylphenols.”; Gassetta Chim. Italiana, 107, 1977, pp. 299-304.
Grese, T.A. et al.: “Structure—Activity Relationships of Selective Estrogen Receptor Modulators: Modifications to the 2-Arylbenzothiophene Core of Raloxifene”; J. Med. Chem. 1997, 40, pp. 146-167.
Grese,T.A. et al.: “Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues: Highly Potent Selective Estrogen Receptor Modulators”; J. Med. Chem. 1998, 41, pp. 1272-1283.
Khan, K.Z. et al.: “Reaction of Dimethyl Sulphoxide & Acetic Anhydride with 3-Substituted 4-Hydroxycoumarinsa”; Indian J. of Chem. vol. 24B, 1985, pp. 42-46.
Nicolaou, K.C. et al.: “Total Synthesis of Amphoteronolide B and Amphotericin B. 1. Strategy and Stereocontrolled Construction of Key Building Blocks”; J. Am. Chem. Soc. 1998, 110, pp. 4672-4685.
Saeed, A. et al.: “Structure—Activity Relationship of Antiestrogens. Studies on 2,3-Diaryl-1-benzopyrans”; J. Med. Chem. 1990, 33, pp. 3210-3216.
Sharma, A.P. et al.: “Structure—Activity Relationship of Antiestrogens. Effect of the Side Chain and Its Position on the Activity of 2,3-Diaryl-2H-1-benzopyrans”; J. Med. Chem. 1990 33, 3216-3222.
Sharma, A.P. et al.: “Structure—Activity Relationship of Antiestrogens. Phenolic Analogues of 2,3-Diaryl-2H-1-benzopyrans”; J. Med. Chem. 1990, 33, pp. 3222-3229.
Welshons, W.V. et al.: “Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol”; Breast Cancer Research and Treatment 10: 1987, pp. 169-175.
Jain Nareshkumar F.
Kanojia Ramesh M.
Ng Raymond
Sui Zhihua
Xu Jiayi
LandOfFree
Heteroatom containing tetracyclic derivatives as selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroatom containing tetracyclic derivatives as selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroatom containing tetracyclic derivatives as selective... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3586294